Skip to content
healthcare.dev

Rasagiline

NDC 33342-309, Rasagiline, tablet, from Macleods Pharmaceuticals Limited.

Product NDC
33342-309
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208866
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE1 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
33342-309-073334203090730 TABLET in 1 BOTTLE (33342-309-07)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e8771c7e-5ecf-47dc-a0fd-4d12e85631a6
  • NADAC price for package 33342030907

    GET /v1/drugs/nadac/33342030907

Use it

Look up 33342-309 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-309 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-309. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.